AGBL5-AS1

Across TCGA pan-cancer cohorts, AGBL5-AS1 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated AGBL5-AS1 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher AGBL5-AS1 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated AGBL5-AS1 expression acts as an unfavorable survival marker, although some lineages such as MESO and UCEC show a favorable association.

MESO, ACC, and UCEC are the cancer types where AGBL5-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	DFS	Quartile	II,III,IV	0.470	0.246	.005	64	view →
ACC	DFS	Quartile	All	0.393	0.777	.004	51	view →
UCEC	DFS	Quartile	IV	0.695	0.264	.008	12	view →
KIRC	DFS	Median	II,III,IV	0.440	0.602	.010	11	view →
DLBC	DFS	Median	III,IV	0.140	0.917	.010	10	view →
TGCT	DFS	Median	All	0.902	0.767	.005	8	view →
PAAD	OS	Median	III,IV	0.629	1.000	.022	6	view →
COAD	DFS	Quartile	III,IV	0.552	0.250	.018	6	view →
THCA	DFS	Quartile	II,III,IV	0.845	0.944	.021	6	view →
STAD	DFS	Median	II,III,IV	0.419	0.296	.012	6	view →
READ	DFS	Tertile	IV	1.000	0.179	.024	6	view →
BLCA	OS	Median	All	0.745	0.674	.025	5	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

AGBL5-AS1–MESO (DFS)

Open the MESO breakdown →